{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:06:59Z","timestamp":1788869219568,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"PSC-CUNY","award":["66391-00 44"],"award-info":[{"award-number":["66391-00 44"]}]},{"name":"PSC-CUNY","award":["66391-00 45"],"award-info":[{"award-number":["66391-00 45"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.bbrc.2014.12.029","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T21:36:04Z","timestamp":1418420164000},"page":"683-688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Sigma 1 Receptor antagonist potentiates the anti-cancer effect of p53 by regulating ER stress, ROS production, Bax levels, and caspase-3 activation"],"prefix":"10.1016","volume":"456","author":[{"given":"Mireille","family":"Happy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Dejoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia K.","family":"Zajac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briseida","family":"Cortez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karabi","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Aderemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira","family":"Sauane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2014.12.029_b0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3389\/fonc.2014.00285","article-title":"p53 family and cellular stress responses in cancer","volume":"4","author":"Pflaum","year":"2014","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.bbrc.2014.12.029_b0010","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","article-title":"Mutant p53 in cancer: new functions and therapeutic opportunities","volume":"25","author":"Muller","year":"2014","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.bbrc.2014.12.029_b0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/2159-8290.CD-13-0136","article-title":"Contribution of p53 to metastasis","volume":"4","author":"Powell","year":"2014","journal-title":"Cancer Discov."},{"issue":"11","key":"10.1016\/j.bbrc.2014.12.029_b0020","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1517\/14712598.2013.845662","article-title":"Advances in adenovirus-mediated p53 cancer gene therapy","volume":"13","author":"Tazawa","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.bbrc.2014.12.029_b0025","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.2147\/OTT.S50483","article-title":"Clinical utility of recombinant adenoviral human p53 gene therapy: current perspectives","volume":"7","author":"Chen","year":"2014","journal-title":"Onco. Targets Ther."},{"issue":"2","key":"10.1016\/j.bbrc.2014.12.029_b0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.cgt.7700870","article-title":"Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial","volume":"13","author":"Atencio","year":"2006","journal-title":"Cancer Gene Ther."},{"issue":"12","key":"10.1016\/j.bbrc.2014.12.029_b0035","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/jgm.1113","article-title":"AdDelta24 and the p53-expressing variant AdDelta24-p53 achieve potent anti-tumor activity in glioma when combined with radiotherapy","volume":"9","author":"Idema","year":"2007","journal-title":"J. Gene Med."},{"issue":"1","key":"10.1016\/j.bbrc.2014.12.029_b0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.canlet.2011.03.021","article-title":"Enhanced antitumor efficacy of a novel fiber chimeric oncolytic adenovirus expressing p53 on hepatocellular carcinoma","volume":"307","author":"Chen","year":"2011","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.bbrc.2014.12.029_b0045","doi-asserted-by":"crossref","first-page":"314.S","DOI":"10.1158\/1535-7163.MCT-12-0869","article-title":"Dual programmed cell death pathways induced by p53 transactivation overcome resistance to oncolytic adenovirus in human osteosarcoma cells","volume":"12","author":"Hasei","year":"2013","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.bbrc.2014.12.029_b0050","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1517\/13543776.2013.769522","article-title":"Sigma receptor modulators: a patent review","volume":"23","author":"Collina","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.bbrc.2014.12.029_b0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/138161207779313740","article-title":"Imaging sigma receptors: applications in drug development","volume":"13","author":"Collier","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbrc.2014.12.029_b0060","article-title":"Potential applications for sigma receptor ligands in cancer diagnosis and therapy","author":"van Waarde","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.bbrc.2014.12.029_b0065","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4155\/fmc.10.279","article-title":"Early development of sigma-receptor ligands","volume":"3","author":"Narayanan","year":"2011","journal-title":"Future Med. Chem."},{"issue":"4","key":"10.1016\/j.bbrc.2014.12.029_b0070","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1124\/mol.109.062539","article-title":"Detergent-resistant microdomains determine the localization of sigma-1 receptors to the endoplasmic reticulum\u2013mitochondria junction","volume":"77","author":"Hayashi","year":"2010","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbrc.2014.12.029_b0075","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cell.2007.08.036","article-title":"Sigma-1 Receptor chaperones at the ER\u2013mitochondrion interface regulate Ca(2+) signaling and cell survival","volume":"131","author":"Hayashi","year":"2007","journal-title":"Cell"},{"issue":"14","key":"10.1016\/j.bbrc.2014.12.029_b0080","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.1158\/0008-5472.CAN-03-3180","article-title":"Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo","volume":"64","author":"Spruce","year":"2004","journal-title":"Cancer Res."},{"issue":"31","key":"10.1016\/j.bbrc.2014.12.029_b0085","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.2174\/138161210793563365","article-title":"Sigma receptors in oncology: therapeutic and diagnostic applications of sigma ligands","volume":"16","author":"van Waarde","year":"2010","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.bbrc.2014.12.029_b0090","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbrc.2013.08.057","article-title":"Sigma 1 Receptor plays a prominent role in IL-24-induced cancer-specific apoptosis","volume":"439","author":"Do","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11\u201312","key":"10.1016\/j.bbrc.2014.12.029_b0095","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.mad.2012.09.005","article-title":"Sigma 1 Receptor stimulation protects against oxidative damage through suppression of the ER stress responses in the human lens","volume":"133","author":"Wang","year":"2012","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bbrc.2014.12.029_b0100","doi-asserted-by":"crossref","first-page":"e1332","DOI":"10.1038\/cddis.2014.301","article-title":"Fluvoxamine alleviates ER stress via induction of Sigma-1 receptor","volume":"5","author":"Omi","year":"2014","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.bbrc.2014.12.029_b0105","doi-asserted-by":"crossref","first-page":"e76941","DOI":"10.1371\/journal.pone.0076941","article-title":"Sigma-1 receptor chaperone at the ER\u2013mitochondrion interface mediates the mitochondrion\u2013ER-nucleus signaling for cellular survival","volume":"8","author":"Mori","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bbrc.2014.12.029_b0110","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/sj.onc.1209890","article-title":"HIF-1alpha contributes to tumour-selective killing by the sigma receptor antagonist rimcazole","volume":"26","author":"Achison","year":"2007","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.bbrc.2014.12.029_b0115","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(95)00115-2","article-title":"Sigma binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture","volume":"278","author":"Brent","year":"1995","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbrc.2014.12.029_b0120","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1167\/iovs.07-1101","article-title":"Sigma-1 Receptors protect RGC-5 cells from apoptosis by regulating intracellular calcium, Bax levels, and caspase-3 activation","volume":"49","author":"Tchedre","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.bbrc.2014.12.029_b0125","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/bph.12041","article-title":"Inhibition of endothelial cell Ca2+ entry and transient receptor potential channels by Sigma-1 receptor ligands","volume":"168","author":"Amer","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.bbrc.2014.12.029_b0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejphar.2012.01.030","article-title":"The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elements","volume":"682","author":"Pal","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbrc.2014.12.029_b0135","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1073\/pnas.98.2.491","article-title":"Regulating ankyrin dynamics: roles of sigma-1 receptors","volume":"98","author":"Hayashi","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"10","key":"10.1016\/j.bbrc.2014.12.029_b0140","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.bbamcr.2014.01.009","article-title":"The role of MAPK signalling pathways in the response to endoplasmic reticulum stress","volume":"1843","author":"Darling","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bbrc.2014.12.029_b0145","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1124\/jpet.109.160960","article-title":"Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaB","volume":"332","author":"Meunier","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"10","key":"10.1016\/j.bbrc.2014.12.029_b0150","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s13238-014-0089-1","article-title":"Mitochondria-mediated apoptosis in mammals","volume":"5","author":"Xiong","year":"2014","journal-title":"Protein Cell"},{"issue":"12","key":"10.1016\/j.bbrc.2014.12.029_b0155","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.tins.2012.09.007","article-title":"The sigma-1 receptor: roles in neuronal plasticity and disease","volume":"35","author":"Kourrich","year":"2012","journal-title":"Trends Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.bbrc.2014.12.029_b0160","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2013.01.068","article-title":"Sigma 1 receptor: a new therapeutic target for pain","volume":"716","author":"Zamanillo","year":"2013","journal-title":"Eur. J. Pharmacol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14021949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X14021949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T21:21:35Z","timestamp":1537996895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X14021949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0006291X14021949"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.12.029","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sigma 1 Receptor antagonist potentiates the anti-cancer effect of p53 by regulating ER stress, ROS production, Bax levels, and caspase-3 activation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2014.12.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}